News

All news

CSR Events General PERSONAL CARE Press release Products & Technologies Protéus

Sale of our Limoges Botanical Actives and In Vitro Diagnostics activities to Solabia

SEQENS today announced the sale of its Botanical Actives and In Vitro Diagnostics (“IVD”) activities located in Limoges (France) to Solabia, a global player specializing in high‑value natural ingredients for personal care, life sciences and diagnostics applications.

NEO Solvents: 5 Criteria for a more Sustainable Chemistry

Formulating Differently: Biobased Diols, the Key to Ecofriendly & Effective Cosmetics

SEQENS new antiwear additive ROSCAN® 6253NV is registered on the LUSC list.

Pharma

Brenntag and SEQENS partner for the commercialization of non-GMP pharmaceutical intermediates in Europe

At the Roussillon site, the development of the future paracetamol production unit is progressing steadily.

SEQENS: Exemplary Ecovadis scores in 2025

CSR

SEQENS: a benchmark in CSR recognized by Ecovadis

CELLforCURE : CELL 2025 UK, Advanced Therapies US, ATMP Sweden and More, let’s meet !

BBG Advanced Therapies and CELLforCURE partner to provide transatlantic manufacturing solutions for ATMPs

Key Visual SEQENS Personal Care Webinar

SEQENS Personal Care at InCosmetics Asia, come and meet us !

CELLforCURE by SEQENS to Manufacture Galapagos’ CAR T-Cell Therapy Candidates for Upcoming Trials

Key Visual SEQENS Personal Care Webinar

SEQENS Personal Care WEBINAR

1 2 3 … 6

Contact